Table 3.
Univariable analysis: comorbidities (n=447)
| Comorbidity | Catastrophising mean±SD (n) |
p Value catastrophising | |
|---|---|---|---|
| Comorbidity=yes | Comorbidity=no | ||
| Diabetes | 1.4±0.8 (8) | 1.1±0.8 (375) | 0.034 |
| Chronic respiratory disease | 1.2±0.8 (36) | 1.1±0.8 (349) | 0.031 |
| Chronic liver damage | 1.5±0.9 (10) | 1.1±0.8 (370) | 0.007 |
| Chronic gastrointestinal disorders | 1.3±0.8 (26) | 1.0±0.8 (355) | 0.002 |
| Mental illness | 1.7±0.8 (38) | 1.0±0.7 (342) | <0.001 |
| Arthrosis | 1.2±0.8 (86) | 1.0±0.7 (295) | 0.021 |
| Scarring changes of skin | 1.3±0.8 (47) | 1.0±0.8 (332) | <0.001 |
| Fibromyalgia | 1.4±0.8 (27) | 1.1±0.8 (347) | 0.014 |
| Stroke | 1.9±0.9 (9) | 1.1±0.8 (376) | 0.023 |
| Hypertension | NS | ||
| Myocardial infarction | NS | ||
| Chronic kidney damage | NS | ||
| Cancer | NS | ||
| Hypercholesterolaemia | NS | ||
| Osteoporosis | NS | ||
| Thrombosis | NS | ||
| Miscarriages | NS | ||
| Early menopause | NS | ||
Data are means and SD, n: number of cases. Means are depending on existence of comorbidities (comorbidity=yes, means: comorbidity exists; comorbidity=no, means: comorbidity does not exist). The p values for catastrophising were derived from the Mann–Whitney U test. As there were no significant associations regarding coping, it is not listed in the table.
NS, not significant.